Detection and importance of micrometastases in histologically negative lymph nodes in endometrial carcinoma

European Journal of Gynaecological Oncology

Volumn 32, Issue 6, 2011, Pages 619-625

  Erkanli, S ^a,b,c   Bolat, F ^a,b,c   Seydaoglu, G ^a,b,c  

^a ACIBADEM UNIVERSITY   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

^c CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Endometrial carcinoma; Lymph nodes; Micrometastases

Indexed keywords

CYTOKERATIN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MICROMETASTASIS; RECURRENCE FREE SURVIVAL;

AGED; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM MICROMETASTASIS; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84855509739     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Smith R.A., Cokkinides V., Eyre H.J.: "American Cancer Society guidelines for the early detection of cancer". CA. Cancer J. Clin., 2003, 53, 27.
2. Abeler V.M., Kjorstad K.E.: "Endometrial adenocarcinoma in Norway. A study of a total population". Cancer, 1991, 67, 3093.
3. Creasman W.T., Morrow C.P., Bundy B.N., Homesley H.D., Graham J.E., Heller P.B.: "Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study". Cancer, 1987, 60, 2035.
4. Keys H.M., Roberts J.A., Brunetto V.L., Zaino R.J., Spirtos N.M., Bloss J.D. et al.: "A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study". Gynecol. Oncol., 2004, 92, 744.
5. Moll R., Franke W.W., Schiller D.L., Geiger B., Krepler R.: "The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells". Cell, 1982, 31, 11.
6. Lindemann F., Schlimok G., Dirschedl P., Witte J., Riethmuller G.: "Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients". Lancet, 1992, 340, 685.
7. Listrom M.B., Dalton L.W.: "Comparison of keratin monoclonal antibodies MAK-6, AE1:AE3, and CAM-5.2". Am. J. Clin. Pathol., 1987, 88, 297.
8. Reich O., Winter R., Pickel H., Tamussino K., Haas J., Petru E.: "Does the size of pelvic lymph nodes predict metastatic involvement in patients with endometrial cancer". Int. J. Gynecol. Cancer, 1996, 6, 445.
9. Fishman A., Klein A., Zemer R., Zimlichman S., Bernheim J., Cohen I., Altaras M.M.: "Detection of micrometastasis by cytokeratin-20 (reverse transcription polymerase chain reaction) in lymph nodes of patients with endometrial cancer". Gynecol. Oncol., 2000, 77, 399.
10. Cote R.J., Peterson H.F., Chaiwun B., Gelber R.D., Goldhirsch A., Castiglione-Gertsch M. et al.: "Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study group". Lancet, 1999, 354, 896.
11. Passlick B., Izbicki J.R., Kubuschok B., Nathrath W., Thetter O., Pichlmeier U. et al.: "Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer". J. Clin. Oncol., 1994, 12, 1827.
12. Yabushita H., Shimazu M., Yamada H., Sawaguchi K., Noguchi M., Nakanishi M. et al.: "Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer". Gynecol. Oncol., 2001, 80, 139.
13. Bosquet J.G., Keeney G.L., Mariani A., Webb M.J., Cliby W.A.: "Cytokeratin staining of resected lymph nodes may improve the sensitivity of surgical staging for endometrial cancer". Gynecol. Oncol., 2003, 91, 518.
14. Amezcua C.A., Macdonald H.R., Lum C.A., Yi W., Muderspach L.I., Roman L.D., Felix J.C.: "Endometrial cancer patients have a significant risk of harboring isolated tumor cells in histologically negative lymph nodes". Int. J. Gynecol. Cancer, 2006, 16, 1336.
15. Edge S.B., Byrd D.R., Compton C.C., Fritz A.G., Grene F.L., Trotti A.: "American Joint Committee on Cancer (AJCC) Cancer Staging Manual". Breast, Part VII, Seventh edition, New York, Springer, 2010, 345.
16. Mariani A., Webb M.J., Keeney G.L., Aletti G., Podratz K.C.: "Predictors of lymphatic failure in endometrial cancer". Gynecol. Oncol., 2002, 84, 437.
17. Chuang L., Burke T.W., Tornos C., Marino B.D., Mitchell M.F., Tortolero-Luna G. et al.: "Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes". Gynecol. Oncol., 1995, 58, 189.
18. Chan J.K., Urban R., Cheung M.K., Shin J.Y., Husain A., Teng N.N. et al.: "Lymphadenectomy in endometrioid uterine cancer staging: how many lymph nodes are enough? A study of 11,443 patients". Cancer, 2007, 109, 2454.
19. Freeman J.A., Esrig D., Grossfeld G.D., Stein J.P., Chen S.C., Young L.L. et al.: "Incidence of occult lymph node metastases in pathological Stage C (pT3N0) prostate cancer". J. Urol., 1995, 154, 474.
20. Maehara Y., Oshiro T., Endo K., Baba H., Oda S., Ichiyoshi Y. et al.: "Clinical significance of occult micrometastasis lymph nodes from patients with early gastric cancer who died of recurrence". Surgery, 1996, 119, 397.